Concepts (313)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Paracoccidioides | 34 | 2015 | 37 | 3.410 |
Why?
|
| Paracoccidioidomycosis | 23 | 2015 | 25 | 2.870 |
Why?
|
| Histoplasmosis | 10 | 2018 | 24 | 1.760 |
Why?
|
| Antifungal Agents | 12 | 2014 | 126 | 1.620 |
Why?
|
| Lung Diseases, Fungal | 7 | 2015 | 34 | 1.160 |
Why?
|
| Histoplasma | 7 | 2018 | 16 | 0.820 |
Why?
|
| Acquired Immunodeficiency Syndrome | 4 | 2016 | 138 | 0.750 |
Why?
|
| Coinfection | 5 | 2021 | 56 | 0.740 |
Why?
|
| Spores, Fungal | 7 | 2015 | 21 | 0.730 |
Why?
|
| Triazoles | 3 | 2006 | 55 | 0.680 |
Why?
|
| Adrenal Insufficiency | 2 | 2010 | 10 | 0.650 |
Why?
|
| Adrenal Glands | 2 | 2010 | 33 | 0.650 |
Why?
|
| AIDS-Related Opportunistic Infections | 3 | 2018 | 68 | 0.620 |
Why?
|
| Lung | 11 | 2013 | 937 | 0.550 |
Why?
|
| Fluconazole | 2 | 2014 | 13 | 0.520 |
Why?
|
| Drug Resistance, Fungal | 1 | 2014 | 10 | 0.470 |
Why?
|
| Antigens, Fungal | 5 | 2018 | 57 | 0.450 |
Why?
|
| Mice, Inbred BALB C | 19 | 2015 | 892 | 0.430 |
Why?
|
| Cryptococcosis | 1 | 2014 | 79 | 0.430 |
Why?
|
| Host-Pathogen Interactions | 2 | 2015 | 261 | 0.430 |
Why?
|
| Cryptococcus neoformans | 1 | 2014 | 148 | 0.410 |
Why?
|
| Tuberculosis | 2 | 2016 | 294 | 0.410 |
Why?
|
| Itraconazole | 4 | 2012 | 13 | 0.350 |
Why?
|
| Drug Therapy, Combination | 2 | 2010 | 463 | 0.330 |
Why?
|
| Hydrocortisone | 1 | 2010 | 192 | 0.300 |
Why?
|
| Fungal Proteins | 5 | 2013 | 147 | 0.290 |
Why?
|
| Postoperative Complications | 2 | 2004 | 1261 | 0.260 |
Why?
|
| Male | 27 | 2025 | 29368 | 0.260 |
Why?
|
| Salvage Therapy | 1 | 2006 | 73 | 0.250 |
Why?
|
| Leptospirosis | 1 | 2025 | 2 | 0.250 |
Why?
|
| Colombia | 8 | 2018 | 22 | 0.240 |
Why?
|
| Skin | 1 | 2008 | 377 | 0.240 |
Why?
|
| Candidiasis | 1 | 2004 | 51 | 0.220 |
Why?
|
| Amphotericin B | 2 | 2014 | 23 | 0.220 |
Why?
|
| Mucormycosis | 1 | 2003 | 10 | 0.210 |
Why?
|
| Oxidoreductases | 2 | 2015 | 64 | 0.210 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2014 | 93 | 0.200 |
Why?
|
| Humans | 33 | 2025 | 62462 | 0.200 |
Why?
|
| Plant Proteins | 2 | 2015 | 85 | 0.200 |
Why?
|
| Mitochondrial Proteins | 2 | 2015 | 103 | 0.200 |
Why?
|
| Soil Microbiology | 1 | 2002 | 8 | 0.200 |
Why?
|
| Mice | 20 | 2015 | 10768 | 0.200 |
Why?
|
| Adult | 13 | 2025 | 16567 | 0.200 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2008 | 35 | 0.190 |
Why?
|
| Virulence Factors | 2 | 2013 | 85 | 0.190 |
Why?
|
| Disease Models, Animal | 8 | 2015 | 2165 | 0.190 |
Why?
|
| Opisthorchiasis | 1 | 2021 | 1 | 0.190 |
Why?
|
| Disease Outbreaks | 1 | 2002 | 113 | 0.190 |
Why?
|
| Antibodies, Fungal | 4 | 2011 | 12 | 0.180 |
Why?
|
| Strongyloidiasis | 1 | 2021 | 10 | 0.180 |
Why?
|
| Animals | 22 | 2025 | 20531 | 0.170 |
Why?
|
| Lung Diseases | 1 | 2002 | 175 | 0.170 |
Why?
|
| Cytokines | 6 | 2011 | 933 | 0.170 |
Why?
|
| Middle Aged | 11 | 2025 | 17294 | 0.170 |
Why?
|
| Retrospective Studies | 5 | 2018 | 6486 | 0.170 |
Why?
|
| Fibrinogen | 3 | 2008 | 32 | 0.160 |
Why?
|
| Fibronectins | 3 | 2008 | 43 | 0.160 |
Why?
|
| Anti-HIV Agents | 2 | 2014 | 154 | 0.160 |
Why?
|
| HIV Infections | 3 | 2016 | 962 | 0.150 |
Why?
|
| Self Care | 2 | 2011 | 212 | 0.150 |
Why?
|
| Follow-Up Studies | 3 | 2014 | 2439 | 0.150 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2018 | 25 | 0.150 |
Why?
|
| Microbial Viability | 3 | 2015 | 58 | 0.150 |
Why?
|
| Female | 14 | 2025 | 32378 | 0.140 |
Why?
|
| Macrophage Activation | 3 | 2008 | 119 | 0.140 |
Why?
|
| Adolescent | 8 | 2025 | 6147 | 0.140 |
Why?
|
| Aspartate Aminotransferases | 1 | 2016 | 28 | 0.130 |
Why?
|
| Alanine Transaminase | 1 | 2016 | 38 | 0.130 |
Why?
|
| Phylogeny | 3 | 2007 | 367 | 0.130 |
Why?
|
| Cell Adhesion Molecules | 2 | 2007 | 89 | 0.130 |
Why?
|
| Mycelium | 3 | 2015 | 4 | 0.120 |
Why?
|
| Macrophages, Peritoneal | 2 | 2007 | 77 | 0.120 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2014 | 203 | 0.120 |
Why?
|
| Gene Expression Regulation, Fungal | 3 | 2013 | 129 | 0.120 |
Why?
|
| Meningitis, Cryptococcal | 1 | 2014 | 14 | 0.120 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 240 | 0.110 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2014 | 45 | 0.110 |
Why?
|
| Viral Load | 1 | 2014 | 229 | 0.110 |
Why?
|
| Drug Monitoring | 1 | 2014 | 118 | 0.110 |
Why?
|
| HIV | 1 | 2013 | 70 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2011 | 687 | 0.100 |
Why?
|
| Deoxycholic Acid | 1 | 2012 | 7 | 0.100 |
Why?
|
| Recurrence | 1 | 2014 | 630 | 0.100 |
Why?
|
| Macrophages | 5 | 2013 | 1039 | 0.100 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 724 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2010 | 1582 | 0.100 |
Why?
|
| Sensitivity and Specificity | 5 | 2018 | 1138 | 0.100 |
Why?
|
| Drug Combinations | 1 | 2012 | 151 | 0.100 |
Why?
|
| Dihydropteroate Synthase | 1 | 2012 | 5 | 0.100 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2012 | 18 | 0.100 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2003 | 78 | 0.100 |
Why?
|
| Pneumocystis carinii | 1 | 2012 | 8 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 4 | 2015 | 201 | 0.100 |
Why?
|
| Molecular Chaperones | 1 | 2012 | 99 | 0.100 |
Why?
|
| Aged | 7 | 2025 | 14203 | 0.100 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2012 | 19 | 0.100 |
Why?
|
| Glycoproteins | 1 | 2013 | 187 | 0.100 |
Why?
|
| Young Adult | 6 | 2025 | 4610 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 2 | 2012 | 514 | 0.090 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2012 | 65 | 0.090 |
Why?
|
| Poverty | 2 | 2011 | 295 | 0.090 |
Why?
|
| Adaptation, Physiological | 1 | 2012 | 128 | 0.090 |
Why?
|
| Melanins | 1 | 2011 | 24 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2018 | 453 | 0.090 |
Why?
|
| Child, Preschool | 3 | 2011 | 1928 | 0.090 |
Why?
|
| Cell Adhesion | 2 | 2010 | 207 | 0.090 |
Why?
|
| Cohort Studies | 3 | 2018 | 2530 | 0.090 |
Why?
|
| Risk Factors | 3 | 2025 | 5288 | 0.090 |
Why?
|
| Pheromones | 1 | 2011 | 22 | 0.090 |
Why?
|
| Pentoxifylline | 1 | 2010 | 8 | 0.090 |
Why?
|
| Laminin | 2 | 2008 | 78 | 0.090 |
Why?
|
| Estrogens | 1 | 2011 | 115 | 0.080 |
Why?
|
| Histocytochemistry | 4 | 2011 | 47 | 0.080 |
Why?
|
| Pulmonary Fibrosis | 1 | 2010 | 79 | 0.080 |
Why?
|
| Health Literacy | 1 | 2011 | 81 | 0.080 |
Why?
|
| Genotype | 1 | 2012 | 649 | 0.080 |
Why?
|
| Immunologic Factors | 1 | 2010 | 104 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2010 | 761 | 0.080 |
Why?
|
| Interferon-gamma | 2 | 2013 | 567 | 0.080 |
Why?
|
| Biopsy | 2 | 2009 | 429 | 0.080 |
Why?
|
| Mycological Typing Techniques | 2 | 2006 | 2 | 0.080 |
Why?
|
| Fludrocortisone | 1 | 2009 | 4 | 0.080 |
Why?
|
| Prednisone | 1 | 2009 | 86 | 0.080 |
Why?
|
| Nitric Oxide | 2 | 2007 | 173 | 0.080 |
Why?
|
| X-Rays | 1 | 2008 | 46 | 0.070 |
Why?
|
| Muramidase | 1 | 2008 | 46 | 0.070 |
Why?
|
| Macrophages, Alveolar | 1 | 2008 | 64 | 0.070 |
Why?
|
| Interferon-alpha | 1 | 2008 | 102 | 0.070 |
Why?
|
| Cluster Analysis | 1 | 2008 | 255 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2013 | 612 | 0.070 |
Why?
|
| Chitin Synthase | 1 | 2007 | 12 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 173 | 0.070 |
Why?
|
| Ferrous Compounds | 1 | 2007 | 12 | 0.070 |
Why?
|
| Ethmoid Sinusitis | 1 | 2006 | 1 | 0.070 |
Why?
|
| Maxillary Sinusitis | 1 | 2006 | 4 | 0.070 |
Why?
|
| Meningitis, Fungal | 1 | 2006 | 2 | 0.070 |
Why?
|
| Radiography | 1 | 2008 | 533 | 0.060 |
Why?
|
| Microsatellite Repeats | 1 | 2006 | 38 | 0.060 |
Why?
|
| Cerebrospinal Fluid | 1 | 2006 | 23 | 0.060 |
Why?
|
| Mannose-Binding Lectins | 1 | 2006 | 22 | 0.060 |
Why?
|
| Health Behavior | 1 | 2009 | 466 | 0.060 |
Why?
|
| Cation Transport Proteins | 1 | 2006 | 20 | 0.060 |
Why?
|
| Anti-Infective Agents | 1 | 2008 | 148 | 0.060 |
Why?
|
| Complement C3 | 1 | 2006 | 59 | 0.060 |
Why?
|
| Adhesiveness | 1 | 2005 | 13 | 0.060 |
Why?
|
| Genetic Speciation | 1 | 2005 | 6 | 0.060 |
Why?
|
| Spatial Regression | 1 | 2025 | 1 | 0.060 |
Why?
|
| Lectins, C-Type | 1 | 2006 | 90 | 0.060 |
Why?
|
| Dominican Republic | 1 | 2025 | 25 | 0.060 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2005 | 95 | 0.060 |
Why?
|
| Women | 1 | 2005 | 44 | 0.060 |
Why?
|
| Bayes Theorem | 2 | 2021 | 119 | 0.060 |
Why?
|
| Infant | 2 | 2011 | 1591 | 0.060 |
Why?
|
| Algorithms | 1 | 2010 | 1003 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2011 | 794 | 0.060 |
Why?
|
| Molecular Sequence Data | 5 | 2006 | 1988 | 0.060 |
Why?
|
| Cysts | 1 | 2004 | 41 | 0.060 |
Why?
|
| Recombination, Genetic | 1 | 2005 | 245 | 0.060 |
Why?
|
| Culture Media | 2 | 2015 | 78 | 0.050 |
Why?
|
| Abdomen | 1 | 2004 | 92 | 0.050 |
Why?
|
| Genes, Fungal | 1 | 2003 | 57 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2006 | 431 | 0.050 |
Why?
|
| Amino Acid Sequence | 4 | 2013 | 1592 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2005 | 370 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 384 | 0.050 |
Why?
|
| Fungi | 1 | 2003 | 57 | 0.050 |
Why?
|
| Mycoses | 1 | 2003 | 46 | 0.050 |
Why?
|
| Candida | 1 | 2003 | 38 | 0.050 |
Why?
|
| Liver Diseases | 1 | 2004 | 148 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2025 | 775 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 2003 | 106 | 0.050 |
Why?
|
| RNA, Antisense | 2 | 2013 | 51 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2015 | 455 | 0.050 |
Why?
|
| Opisthorchis | 1 | 2021 | 1 | 0.050 |
Why?
|
| Strongyloides stercoralis | 1 | 2021 | 12 | 0.050 |
Why?
|
| Heart Transplantation | 1 | 2003 | 169 | 0.050 |
Why?
|
| Thailand | 1 | 2021 | 98 | 0.050 |
Why?
|
| DNA, Fungal | 2 | 2012 | 58 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 698 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2012 | 5390 | 0.040 |
Why?
|
| Kidney Transplantation | 1 | 2003 | 313 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 3 | 2007 | 406 | 0.040 |
Why?
|
| Child | 2 | 2011 | 4429 | 0.040 |
Why?
|
| Microscopy | 2 | 2011 | 91 | 0.040 |
Why?
|
| Family | 1 | 2002 | 240 | 0.040 |
Why?
|
| Protein Binding | 3 | 2013 | 1595 | 0.040 |
Why?
|
| Cell Line | 3 | 2010 | 2033 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2004 | 1537 | 0.040 |
Why?
|
| Weight Loss | 2 | 2016 | 272 | 0.040 |
Why?
|
| Guatemala | 1 | 2018 | 4 | 0.040 |
Why?
|
| Galactose | 1 | 2018 | 12 | 0.040 |
Why?
|
| Incidence | 2 | 2013 | 1359 | 0.040 |
Why?
|
| Mannans | 1 | 2018 | 20 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2025 | 2529 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2011 | 93 | 0.040 |
Why?
|
| Prevalence | 1 | 2021 | 1343 | 0.030 |
Why?
|
| Life Cycle Stages | 2 | 2008 | 17 | 0.030 |
Why?
|
| Hepatomegaly | 1 | 2016 | 2 | 0.030 |
Why?
|
| Karnofsky Performance Status | 1 | 2016 | 12 | 0.030 |
Why?
|
| Splenomegaly | 1 | 2016 | 24 | 0.030 |
Why?
|
| Leukopenia | 1 | 2016 | 16 | 0.030 |
Why?
|
| Skin Ulcer | 1 | 2016 | 15 | 0.030 |
Why?
|
| Gene Frequency | 2 | 2007 | 119 | 0.030 |
Why?
|
| Lymphadenopathy | 1 | 2016 | 23 | 0.030 |
Why?
|
| Pneumonia | 2 | 2010 | 286 | 0.030 |
Why?
|
| Time Factors | 3 | 2011 | 3737 | 0.030 |
Why?
|
| Headache | 1 | 2016 | 58 | 0.030 |
Why?
|
| Diarrhea | 1 | 2016 | 76 | 0.030 |
Why?
|
| Thrombocytopenia | 1 | 2016 | 52 | 0.030 |
Why?
|
| Macrophage-1 Antigen | 2 | 2006 | 31 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2016 | 101 | 0.030 |
Why?
|
| Dyspnea | 1 | 2016 | 121 | 0.030 |
Why?
|
| Nausea | 1 | 2016 | 112 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2006 | 5554 | 0.030 |
Why?
|
| Vomiting | 1 | 2016 | 137 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2011 | 866 | 0.030 |
Why?
|
| Species Specificity | 2 | 2006 | 334 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 887 | 0.030 |
Why?
|
| Models, Genetic | 2 | 2007 | 258 | 0.030 |
Why?
|
| Cough | 1 | 2016 | 183 | 0.030 |
Why?
|
| Mutation | 2 | 2013 | 2576 | 0.030 |
Why?
|
| Immunodiffusion | 1 | 2013 | 5 | 0.030 |
Why?
|
| HLA-DR Antigens | 1 | 2013 | 26 | 0.030 |
Why?
|
| Epitope Mapping | 1 | 2013 | 50 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2009 | 1076 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 1636 | 0.030 |
Why?
|
| Base Sequence | 2 | 2006 | 1329 | 0.030 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2013 | 179 | 0.030 |
Why?
|
| Complement System Proteins | 1 | 2013 | 115 | 0.030 |
Why?
|
| Oxidants | 1 | 2011 | 18 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2013 | 319 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2011 | 78 | 0.020 |
Why?
|
| Rodent Diseases | 1 | 2011 | 6 | 0.020 |
Why?
|
| Serum | 1 | 2011 | 29 | 0.020 |
Why?
|
| Temperature | 1 | 2012 | 309 | 0.020 |
Why?
|
| Latin America | 1 | 2011 | 16 | 0.020 |
Why?
|
| Serologic Tests | 1 | 2011 | 37 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2011 | 116 | 0.020 |
Why?
|
| Cross Reactions | 1 | 2011 | 131 | 0.020 |
Why?
|
| Virulence | 1 | 2011 | 195 | 0.020 |
Why?
|
| Symptom Assessment | 1 | 2011 | 48 | 0.020 |
Why?
|
| Immunoassay | 1 | 2011 | 70 | 0.020 |
Why?
|
| Reticulin | 1 | 2010 | 1 | 0.020 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2011 | 61 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2011 | 252 | 0.020 |
Why?
|
| Age Distribution | 1 | 2011 | 257 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2012 | 293 | 0.020 |
Why?
|
| Chemokines, CXC | 1 | 2010 | 29 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2010 | 53 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2011 | 107 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2011 | 575 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2012 | 389 | 0.020 |
Why?
|
| DNA, Ribosomal Spacer | 1 | 2009 | 2 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 834 | 0.020 |
Why?
|
| Collagen | 1 | 2010 | 127 | 0.020 |
Why?
|
| Health Surveys | 1 | 2011 | 311 | 0.020 |
Why?
|
| Hydrolases | 1 | 2010 | 82 | 0.020 |
Why?
|
| Yeasts | 1 | 2010 | 51 | 0.020 |
Why?
|
| Peptides | 1 | 2013 | 573 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2010 | 115 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2011 | 462 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 608 | 0.020 |
Why?
|
| Urban Population | 1 | 2009 | 189 | 0.020 |
Why?
|
| Community Health Services | 1 | 2009 | 126 | 0.020 |
Why?
|
| Elastic Tissue | 1 | 2008 | 5 | 0.020 |
Why?
|
| RNA | 1 | 2012 | 420 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2008 | 97 | 0.020 |
Why?
|
| Chitin | 1 | 2008 | 39 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 968 | 0.020 |
Why?
|
| Comorbidity | 1 | 2011 | 1117 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2009 | 290 | 0.020 |
Why?
|
| Deferoxamine | 1 | 2007 | 4 | 0.020 |
Why?
|
| Counseling | 1 | 2009 | 358 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 747 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2013 | 844 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2011 | 2148 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 3246 | 0.020 |
Why?
|
| Sulfur | 1 | 2006 | 16 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 2006 | 52 | 0.020 |
Why?
|
| Haplotypes | 1 | 2007 | 118 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2006 | 62 | 0.020 |
Why?
|
| Methylmannosides | 1 | 2006 | 2 | 0.020 |
Why?
|
| Receptors, Complement 3b | 1 | 2006 | 12 | 0.020 |
Why?
|
| Mice, Congenic | 1 | 2006 | 22 | 0.020 |
Why?
|
| CD11b Antigen | 1 | 2006 | 19 | 0.020 |
Why?
|
| Transferrin | 1 | 2007 | 70 | 0.020 |
Why?
|
| Research Design | 1 | 2009 | 572 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 189 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2006 | 126 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 372 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2009 | 727 | 0.020 |
Why?
|
| South America | 1 | 2005 | 26 | 0.020 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2005 | 14 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2005 | 32 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2005 | 15 | 0.020 |
Why?
|
| CD18 Antigens | 1 | 2005 | 30 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2005 | 54 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2007 | 388 | 0.010 |
Why?
|
| Molecular Weight | 1 | 2005 | 187 | 0.010 |
Why?
|
| DNA Primers | 1 | 2005 | 292 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2006 | 264 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 233 | 0.010 |
Why?
|
| Alleles | 1 | 2006 | 444 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 400 | 0.010 |
Why?
|
| Massachusetts | 1 | 2009 | 2061 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2003 | 71 | 0.010 |
Why?
|
| Diffusion | 1 | 2003 | 83 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 712 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2006 | 869 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2011 | 3016 | 0.010 |
Why?
|
| Neutrophils | 1 | 2003 | 372 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2002 | 609 | 0.010 |
Why?
|
| Inflammation | 1 | 2003 | 1136 | 0.010 |
Why?
|